FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093149 [Registered on: 18/08/2025] Trial Registered Prospectively
Last Modified On: 15/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Dentistry 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   This study compares how well two medicines that is tramadol (a painkiller) and dexamethasone (which helps reduce swelling), works when injected under the gum, to see which one better helps with pain, swelling, and other problems after the surgical removal of a lower wisdom tooth. 
Scientific Title of Study   Comparison Of Efficacy Of Submucosal Injection Of Tramadol Vs Dexamethasone In Reducing Post Operative Sequelae In Impacted Mandibular Third Molar Extraction : A Prospective, Randomised, Placebo Controlled, A Triple Blind Study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  CHATOI SOCIA 
Designation  PG student 
Affiliation  MAULANA AZAD INSTITUTE OF DENTAL COLLEGE 
Address  1ST FLOOR MAULANA AZAD DENTAL COLLEGE, Bahadur Shah Zafar Marg, near Delhi Gate, Maulana Azad Medical College Campus, Balmiki Basti, New Delhi, Delhi,

Central
DELHI
110002
India 
Phone  8787739973  
Fax    
Email  chatoisocia@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR PANKAJ SHARMA 
Designation  PROFESSOR 
Affiliation  MAULANA AZAD INSTITUTE OF DENTAL COLLEGE 
Address  1ST FLOOR MAULANA AZAD DENTAL COLLEGE, Bahadur Shah Zafar Marg, near Delhi Gate, Maulana Azad Medical College Campus, Balmiki Basti, New Delhi, Delhi,

Central
DELHI
110002
India 
Phone  9654958541  
Fax    
Email  Spankajomfs@gmail.com  
 
Details of Contact Person
Public Query
 
Name  CHATOI SOCIA 
Designation  PG student 
Affiliation  MAULANA AZAD INSTITUTE OF DENTAL COLLEGE 
Address  1ST FLOOR MAULANA AZAD DENTAL COLLEGE, Bahadur Shah Zafar Marg, near Delhi Gate, Maulana Azad Medical College Campus, Balmiki Basti, New Delhi, Delhi,


DELHI
110002
India 
Phone  8787739973  
Fax    
Email  chatoisocia@gmail.com  
 
Source of Monetary or Material Support  
maulana azad institute of dental sciences, delhi 
 
Primary Sponsor  
Name  chatoi socia 
Address  1st floor maulana azad institute of dental sciences, delhi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR CHATOI SOCIA  MAULANA AZAD INSTITUTE OF DENTAL SCIENCES  1st floor, Maulana Azad Institute of Dental Sciences, MAMC, Bahadur shah Zafar Marg, central Delhi
Central
DELHI 
8787739973

chatoisocia@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  DEXAMETHASONE  SUBMUCOSAL INJECTION OF 4mg/ml (1ml) DEXAMETHASONE IN MANDIBULAR THIRD MOLAR DISIMPACTION CASES 
Comparator Agent  NORMAL SALINE  SUBMUCOSAL INJECTION OF 1ml of 0.9% NORMAL SALINE IN THE MANDIBULAR THIRD MOLAR DISIMPACTION CASES 
Intervention  TRAMADOL  SUBMUCOSAL INJECTION OF 50mg/ml (1ml) TRAMADOL IN MANDIBULAR THIRD MOLAR DISIMPACTION CASES o 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1 Above 18 years of age, any sex.
2 Impacted mandibular third molar (which require transalveolar extraction) with Pederson difficulty index- moderately difficult (5-7)
3 American Society of Anesthesiologists (physical status classification)- class 1
 
 
ExclusionCriteria 
Details  • Age below 18 years
• Patient with history of any systemic illness
• Patients with pericoronitis or local acute infection at the time of surgery.
• Pregnancy or lactating women.
• Drug allergy to tramadol and dexamethasone.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 

1) Reduction in swelling.
2) Improvement in mouth opening.
3) Reduction in pain.
 

postoperative 1st, 3rd and 7th day
 
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare rescue analgesia needed by the patient (duration & frequency) after submucosal injection of tramadol & dexamethasone postoperatively on 1st, 3rd & 7th day.
2. Side effects of drugs :
Nausea, vomiting, burning & dizziness etc
 
1st 3rd & 7th postoperative day 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   27/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Background:

Surgical removal of impacted mandibular third molars is frequently associated with postoperative sequelae such as pain, swelling, and trismus, which can significantly affect patient comfort and quality of life. Various pharmacological agents have been evaluated to minimize these outcomes. This study aims to compare the efficacy of submucosal injection of tramadol versus dexamethasone in controlling postoperative discomfort following third molar surgery.

Materials and Methods:
A prospective, randomized, placebo-controlled, triple-blind clinical trial was conducted on 90 systemically healthy patients requiring mandibular third molar extraction. Patients were randomly allocated into three groups (n=30 each): Group A received 1 ml of tramadol (50 mg/ml), Group B received 1 ml of dexamethasone (4mg/ml), and Group C received 1 ml of normal saline (placebo) via submucosal injection immediately post-extraction. Standardized surgical protocol and postoperative care were maintained. Pain (measured using a Visual Analog Scale), facial swelling (measured using two-line facial measurement), and trismus (interincisal distance) were assessed on postoperative days 1, 3, and 7.

 
Close